Copyright
©The Author(s) 2022.
World J Clin Oncol. Feb 24, 2022; 13(2): 135-146
Published online Feb 24, 2022. doi: 10.5306/wjco.v13.i2.135
Published online Feb 24, 2022. doi: 10.5306/wjco.v13.i2.135
Figure 2 Percentage of patients with different aneuploidy score levels in breast cancer groups with and without neurotrophic receptor tyrosine kinase amplifications.
Data are from TCGA breast cancer cohort. Black columns: Neurotrophic receptor tyrosine kinase amplified; Grey columns: Neurotrophic receptor tyrosine kinase non-amplified.
- Citation: Stravodimou A, Voutsadakis IA. Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas. World J Clin Oncol 2022; 13(2): 135-146
- URL: https://www.wjgnet.com/2218-4333/full/v13/i2/135.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i2.135